Abstract
Objective
Growth hormone (GH) activity might be implicated in male reproductive function. One previous study has suggested significantly reduced semen quality in untreated acromegalic patients due to both reduced sperm counts and sperm motility.
Design and methods
A retrospective study comprising ten uncontrolled hypogonadal acromegalic patients (median age 29 years) who delivered semen for cryopreservation before initiation of testosterone therapy. Semen variables and hormone concentrations were compared to those of ten non-acromegalic hypogonadal men with pituitary disease (age 31 years) and those of young healthy men.
Results
Acromegalic patients vs. non-acromegalic patients had a higher percentage of progressive motile spermatozoa (62 vs. 47%, p = 0.04). Eight of ten acromegalic patients and 82% of controls had total sperm counts above 39 million and progressive motile spermatozoa above 32% (p = 0.55), corresponding to the WHO 2010 reference levels for expected normal fertility for these variables. Non-acromegalic patients vs. healthy controls had reduced percentage of progressive motile spermatozoa (47 vs. 57%, p = 0.02) and only five of ten patients had semen quality above the WHO reference level, which was significantly lower than observed in healthy controls (p = 0.022). Total sperm counts were similar between both patient groups and controls. There were no differences in reproductive hormone levels between acromegalic patients vs. non-acromegalic patients (p-values between 0.10 and 0.61). Compared to healthy controls both patient groups had severely reduced serum testosterone, calculated free testosterone.
Conclusions
Despite severe hypoandrogenism acromegalic patients had semen quality similar to healthy controls based on determination of the number of progressively motile spermatozoa. By contrast non-acromegalic pituitary patients had reduced sperm motility. Our data do not support reduced semen quality in acromegaly.
Similar content being viewed by others
Data availability statement
The authors confirm that the data supporting the findings of this study are available within the article and in reference number 10.
References
Chandrashekar V, Zaczek D, Bartke A (2004) The consequences of altered somatotropic system on reproduction. Biol Reprod 71(1):17–27
Lobie PE, Breipohl W, Aragon JG, Waters MJ (1990) Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. Endocrinology 126(4):2214–2221
Harvey S, Baumbach WR, Sadeghi H, Sanders EJ (1993) Ultrastructural colocalization of growth hormone binding protein and pituitary hormones in adenohypophyseal cells of the rat. Endocrinology 133(3):1125–1130
Mertani HC, Waters MJ, Jambou R, Gossard F, Morel G (1994) Growth hormone receptor binding protein in rat anterior pituitary. Neuroendocrinology 59(5):483–494
Lee KO, Ng SC, Lee PS, Bongso AT, Taylor EA, Lin TK et al (1995) Effect of growth hormone therapy in men with severe idiopathic oligozoospermia. Eur J Endocrinol/Eur Fed Endocr Soc 132(2):159–162
Ovesen P, Jorgensen JO, Ingerslev J, Ho KK, Orskov H, Christiansen JS (1996) Growth hormone treatment of subfertile males. Fertil Steril 66(2):292–298
Shoham Z, Conway GS, Ostergaard H, Lahlou N, Bouchard P, Jacobs HS (1992) Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil Steril 57(5):1044–1051
Laron Z, Klinger B (1998) Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). Eur J Endocrinol/Eur Fed Endocr Soc 138(2):176–180
Colao A, De Rosa M, Pivonello R, Balestrieri A, Cappabianca P, Di Sarno A et al (2002) (2002) Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly. J Clin Endocrinol Metab 87(9):4193–4197
Andreassen M, Juul A, Feldt-Rasmussen U, Jorgensen N (2018) Semen quality in patients with pituitary disease and adult-onset hypogonadotropic hypogonadism. Endocr Connect 7(4):523–533
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM et al (2018) Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103(5):1715–1744
Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951
Jorgensen N, Joensen UN, Jensen TK, Jensen MB, Almstrup K, Olesen IA et al (2012) Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open 2(4):e000990
Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM et al (2010) World Health Organization reference values for human semen characteristics. Human Reprod Update 16(3):231–245
Lischka A (1987) Investigation of peripheral androgen resistance in genital hypoplasia associated with congenital growth hormone deficiency. Andrologia 19(1):97–102
Pedersen SA, Chrstiansen JS, Jensen S, Jelnes JE, Skakkebrek NE (1989) Growth hormone and reproduction:reduced semen quality in men previously treated for growth hormone deficiency. In: Frisch H, Thorner MO, (eds) International symposium on hormonal regulation of growth. Raven Press, Vienna, pp 273–282; 1989, pp 273–282
Juul A, Andersson AM, Pedersen SA, Jorgensen JO, Christiansen JS, Groome NP, et al (1998) Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study. Horm Res 49(6):269–278.
Carani C, Granata AR, De Rosa M, Garau C, Zarrilli S, Paesano L et al (1999) The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur J Endocrinol/Eur Fed Endocr Soc 140(3):224–230
Lischka A (1987) Molecular biology of androgen action in genital hypoplasia associated with congenital growth hormone deficiency: a "transitory androgen insensitivity syndrome"? Arch Androl 18(3):269–274
Serra C, Bhasin S, Tangherlini F, Barton ER, Ganno M, Zhang A et al (2011) The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle. Endocrinology 152(1):193–206
Bredella MA, Schorr M, Dichtel LE, Gerweck AV, Young BJ, Woodmansee WW et al (2017) Body composition and ectopic lipid changes with biochemical control of acromegaly. J Clin Endocrinol Metab 102(11):4218–4225
Andreassen M, Jensen RB, Jorgensen N, Juul A (2014) Association between GH receptor polymorphism (exon 3 deletion), serum IGF1, semen quality, and reproductive hormone levels in 838 healthy young men. Eur J Endocrinol/Eur Feder Endocr Soc 170(4):555–563
Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wuster C et al (1996) Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81(7):2534–2540
Kaaks R, Lukanova A, Rinaldi S, Biessy C, Soderberg S, Olsson T et al (2003) Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls. Eur J Cancer Prev 12(4):309–315
Erfurth EM, Hagmar LE, Saaf M, Hall K (1996) Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clin Endocrinol 44(6):659–664
Singh A, Hamilton-Fairley D, Koistinen R, Seppala M, James VH, Franks S et al (1990) Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol 124(2):R1–R3
Gafny M, Silbergeld A, Klinger B, Wasserman M, Laron Z (1994) Comparative effects of GH, IGF-I and insulin on serum sex hormone binding globulin. Clin Endocrinol 41(2):169–175
Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB (2009) The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab 94(3):907–913
Andreassen M, Frystyk J, Faber J, Kristensen LO, Juul A (2013) Growth hormone (GH) activity is associated with increased serum oestradiol and reduced anti-Mullerian hormone in healthy male volunteers treated with GH and a GH antagonist. Andrology 1(4):595–601
Zhang B, Shozu M, Okada M, Ishikawa H, Kasai T, Murakami K et al (2010) Insulin-like growth factor I enhances the expression of aromatase P450 by inhibiting autophagy. Endocrinology 151(10):4949–4958
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. The research salary of UFR was sponsored by an unrestricted research grant from the Novo Nordic Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Declaration of interest
There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Andreassen, M., Juul, A., Feldt-Rasmussen, U. et al. Semen quality in hypogonadal acromegalic patients. Pituitary 23, 160–166 (2020). https://doi.org/10.1007/s11102-019-01018-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-019-01018-x